Skip to main content

BioVision to Discover Lung Cancer Biomarkers for Abbott

NEW YORK, Sept. 9 (GenomeWeb News) - BioVision will conduct biomarker discovery research for Abbott, the Hanover, Germany-based company said today.

 

Under the agreement, BioVision will analyze biological samples provided by Abbott to discover lung cancer tumor biomarkers. In return, the company will receive research fees and might obtain milestone and royalty payments, depending on the success of the research.

 

BioVision specializes in the identification of disease-relevant peptides and proteins.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.